Global In Vitro Diagnostics Market

In Vitro Diagnostics Market - Global
Industry Analysis, Size, Share, Growth
and Forecast upto 2018
Transparency Market Research has published a new report that offers an
in-depth study of the global metrology services market. The report, titled
“In Vitro Diagnostics Market - Global Industry Analysis, Size, Share,
Growth, Trends, and Forecast, 2012 - 2018”, is available for sale on the
company’s website. This report offers a 360-degree view of the global in
vitro diagnostics market along with an assessment of the strengths,
weaknesses, opportunities, and threats faced by this market.
Increase in the global population accompanied with an increase in the
cases of chronic infections and diseases such as sexually transmitted
diseases (STDs), diabetes, and cancer have led to the growth of the
global IVD market. Rising healthcare expenditure across the globe has
further boosted the growth of the global IVD market.
The non-invasive and minimally invasive diagnostic tools offered by the
global IVD market are preferred by patients and the doctors alike. This
fits with the general trend in the medical industry towards minimally
invasive procedures, which are more convenient for both parties.
However, reimbursement challenges could restrain the growth of the
global IVD market. Also, uncertain and ambiguous environmental
regulations will threaten the growth of the global IVD market.
Molecular diagnostics have opened new channels for the global IVD
market. In the coming years, epigenomics-based diagnostics are forecast

to be the emerging segment in the global IVD market. Key players in the
in vitro diagnostics market are working on introducing epigenomicsbased
diagnostic products to stay ahead in the competition.
Browse Full Research Report on In Vitro Diagnostics Market:
http://www.transparencymarketresearch.com/in-vitro-diagnostictests.html
The global in vitro diagnostics market has been segmented on the basis
of products and geography. In terms of geography, this market can be
divided into Asia Pacific, Europe, North America, and Rest of the World.
The products in the global in vitro diagnostics market are clinical
chemistry IVDs, immunoassay IVDs, blood testing IVDs, molecular
diagnostics, diabetes testing IVDs, and other IVDs.
The increasing demand for IVDs from regions such as Asia Pacific and
Latin America is rapidly changing the landscape of the in vitro
diagnostics market across the globe. Back in 2011, Europe and North
America held a large share in the in vitro diagnostics market due to the
presence of organized clinical research facilities and growing healthcare
awareness. However, the tables have turned, as developing economies
are now in the limelight and are attracting important market players with
their pool of unmet opportunities.
The main drivers for the in vitro diagnostics market in Europe are the
growing incidence of illnesses such as tuberculosis, sexually transmitted
infections, and pneumonia, cardiovascular diseases (CVDs), diabetes
mellitus, and cancer, and growing interest in quick diagnostics and
point-of-care testing.

The report suggests that clinical chemistry IVDs dominated the market
in China, India, and the U.S in 2011. However, analysts predict that the
molecular diagnostics segment will outpace the growth of other
segments, as it helps in identifying diseases at a very early stage. In
addition to this, the growing number of diabetics will also drive the
global diabetes testing IVDs market, which includes blood glucose
meters and glucose testing strips.
As the diagnostic companies are working with pharmaceutical
organizations for improving diagnostic procedures, the market will
witness a huge array of convenient testing options in the near future.
The report on the global in vitro diagnostics market also profiles some of
the key players in the market to provide a clear picture of the
competitive landscape.
The important companies in the global in vitro diagnostics market are
Abbott Laboratories Inc., Bayer AG, Alere Inc., Becton Dickinson and
Company, Siemens Healthcare (a division of Siemens AG), Beckman
Coulter Inc., Biomerieux SA, Danaher Corporation, Gen-Probe
Incorporated, Life Technologies Corporation, Johnson and Johnson,
Thermo Fisher Scientific Corporation, and F. Hoffmann-La Roche Ltd.

The section on company profiles includes an overview, financial status,
research and development plans, marketing strategies, and investment
plans for the coming few years.
Browse Full Press Release on In Vitro Diagnostics Market:
Press Release
About Us
Transparency Market Research (TMR) is a global market intelligence
company providing business information reports and services. The
company’s exclusive blend of quantitative forecasting and trend analysis
provides forward-looking insight for thousands of decision makers.
TMR’s experienced team of analysts, researchers, and consultants use
proprietary data sources and various tools and techniques to gather and
analyze information.
TMR’s data repository is continuously updated and revised by a team of
research experts so that it always reflects the latest trends and
information. With extensive research and analysis capabilities,
Transparency Market Research employs rigorous primary and secondary
research techniques to develop distinctive data sets and research material
for business reports.

Contact Us
Transparency Market Research
State Tower,
90 State Street, Suite 700,
Albany NY - 12207
United States
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com